Inmunomodulación y Microambiente Tumoral
ITAM
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (7)
2021
-
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1+ tumour-infiltrating lymphocytes
British Journal of Cancer, Vol. 124, Núm. 6, pp. 1138-1149
2019
-
ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
Molecular Therapy, Vol. 27, Núm. 11, pp. 1878-1891
2017
-
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
PLoS ONE, Vol. 12, Núm. 9
-
Therapeutic blockade of Foxp3 in experimental breast cancer models
Breast Cancer Research and Treatment, Vol. 166, Núm. 2, pp. 393-405
2016
-
MRP1-CD28 bi-specific oligonucleotide aptamers: Target costimulation to drug-resistant melanoma cancer stem cells
Oncotarget, Vol. 7, Núm. 17, pp. 23182-23196
-
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy
Biomaterials, Vol. 91, pp. 73-80
2015
-
A core of kinase-regulated interactomes defines the neoplastic MDSC lineage
Oncotarget, Vol. 6, Núm. 29, pp. 27160-27175